These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38747879)

  • 41. Excess Mortality Associated With the COVID-19 Pandemic-Los Angeles County, March-September 2020.
    Traub E; Amoon AT; Rollin-Alamillo L; Haddix M; Poortinga K; Ibrahim M; Feregrino G; Foo C; Itano A; Lee R; Fisher R; Jarashow C; Balter S; Gounder P
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):233-239. PubMed ID: 33762539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excess deaths from all causes and by COVID-19 in Brazil in 2020.
    Santos AMD; Souza BF; Carvalho CA; Campos MAG; Oliveira BLCA; Diniz EM; Branco MDRFC; Queiroz RCS; Carvalho VA; Araújo WRM; Silva AAMD
    Rev Saude Publica; 2021; 55():71. PubMed ID: 34730751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Causes of Death Collaborators
    Lancet; 2018 Nov; 392(10159):1736-1788. PubMed ID: 30496103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How many more? Under-reporting of the COVID-19 deaths in Brazil in 2020.
    Kupek E
    Trop Med Int Health; 2021 Sep; 26(9):1019-1028. PubMed ID: 34008266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cause-specific mortality for 249 causes in Brazil and states during 1990-2015: a systematic analysis for the global burden of disease study 2015.
    França EB; Passos VMA; Malta DC; Duncan BB; Ribeiro ALP; Guimarães MDC; Abreu DMX; Vasconcelos AMN; Carneiro M; Teixeira R; Camargos P; Melo APS; Queiroz BL; Schmidt MI; Ishitani L; Ladeira RM; Morais-Neto OL; Bustamante-Teixeira MT; Guerra MR; Bensenor I; Lotufo P; Mooney M; Naghavi M
    Popul Health Metr; 2017 Nov; 15(1):39. PubMed ID: 29166948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocysticercosis-related mortality in Brazil, 2000-2011: Epidemiology of a neglected neurologic cause of death.
    Martins-Melo FR; Ramos AN; Cavalcanti MG; Alencar CH; Heukelbach J
    Acta Trop; 2016 Jan; 153():128-36. PubMed ID: 26505283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fetal death as an outcome of acute respiratory distress in pregnancy, during the COVID-19 pandemic: a population-based cohort study in Bahia, Brazil.
    Carvalho-Sauer R; Flores-Ortiz R; Costa MDCN; Teixeira MG; Saavedra R; Niag M; Paixao ES
    BMC Pregnancy Childbirth; 2023 May; 23(1):320. PubMed ID: 37147605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality by cause for eight regions of the world: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9061):1269-76. PubMed ID: 9142060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Appiah-Kubi A; Acharya S; Fein Levy C; Vlachos A; Ostovar G; Murphy K; Farrell A; Brower D; Lipton JM; Wolfe L; Aygun B
    Br J Haematol; 2020 Aug; 190(4):e221-e224. PubMed ID: 32652551
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
    Minniti CP; Zaidi AU; Nouraie M; Manwani D; Crouch GD; Crouch AS; Callaghan MU; Carpenter S; Jacobs C; Han J; Simon J; Glassberg J; Gordeuk VR; Klings ES
    Blood Adv; 2021 Jan; 5(1):207-215. PubMed ID: 33570644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality from systemic erythematosus lupus in Brazil: evaluation of causes according to the government health database.
    Costi LR; Iwamoto HM; Neves DCO; Caldas CAM
    Rev Bras Reumatol Engl Ed; 2017; 57(6):574-582. PubMed ID: 29032927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Impact of the COVID-19 epidemic on total and cause-specific mortality in Rome (Italy) in 2020].
    Asta F; Michelozzi P; De Sario M; Santelli E; Bauleo L; Cozzi I; Vairo F; Davoli M; Porta D
    Epidemiol Prev; 2022; 46(1-2):59-67. PubMed ID: 35354268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.
    Lanzkron S; Carroll CP; Haywood C
    Public Health Rep; 2013; 128(2):110-6. PubMed ID: 23450875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of mortality in sickle cell disease in the United Kingdom.
    Gray A; Anionwu EN; Davies SC; Brozovic M
    J Clin Pathol; 1991 Jun; 44(6):459-63. PubMed ID: 2066423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Boğa C; Asma S; Leblebisatan G; Şen N; Tombak A; Demiroğlu YZ; Yeral M; Akın Ş; Yeşilağaç H; Habeşoğlu MA; Arıboğan A; Kasar M; Korur A; Özdoğu H
    Ann Hematol; 2021 Sep; 100(9):2195-2202. PubMed ID: 34032899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the temporal trend of mortality from sickle cell anemia in Brazil.
    Mota FM; Ferreira Júnior MA; Cardoso AIQ; Pompeo CM; Frota OP; Tsuha DH; Souza AS
    Rev Bras Enferm; 2022; 75(4):e20210640. PubMed ID: 35442313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the effect of the COVID-19 pandemic on the all-cause, cause-specific mortality, YLL, and life expectancy in the first 2 years in an Iranian population-an ecological study.
    Pirayesh Z; Riahi SM; Bidokhti A; Kazemi T
    Front Public Health; 2023; 11():1259202. PubMed ID: 37927873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sickle cell disease related mortality in the United States (1999-2009).
    Hamideh D; Alvarez O
    Pediatr Blood Cancer; 2013 Sep; 60(9):1482-6. PubMed ID: 23637037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
    Panepinto JA; Brandow A; Mucalo L; Yusuf F; Singh A; Taylor B; Woods K; Payne AB; Peacock G; Schieve LA
    Emerg Infect Dis; 2020 Oct; 26(10):2473-2476. PubMed ID: 32639228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.